WINDTREE THERAPEUTICS INC /DE/ Deferred Income Tax Liabilities, Net
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Deferred Income Tax Liabilities, Net of $1.64 million as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2025-11-19
- 2025-09-30: Deferred Income Tax Liabilities, Net $1.64M.
- 2025-06-30: Deferred Income Tax Liabilities, Net $5.08M.
- 2025-03-31: Deferred Income Tax Liabilities, Net $4.64M.
- 2024-12-31: Deferred Income Tax Liabilities, Net $4.53M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2025-09-30 | $1.64M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $5.08M 10-Q · filed 2025-08-19 |
| 2025-03-31 | $4.64M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.53M 10-Q · filed 2025-11-19 |
| 2024-09-30 | $4.89M 10-Q · filed 2024-11-26 |
| 2024-06-30 | $4.77M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $4.86M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $5.06M 10-K · filed 2025-04-15 |
| 2023-09-30 | $4.81M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.98M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $5.08M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $5.06M 10-K · filed 2024-04-16 |
| 2022-09-30 | $6.20M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.64M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $6.88M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.11M 10-K · filed 2023-03-31 |
| 2021-09-30 | $8.71M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $8.67M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $16.68M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $16.78M 10-K · filed 2022-03-31 |
| 2020-09-30 | $16.37M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $16.13M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $15.76M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $15.82M 10-K · filed 2021-03-29 |
| 2018-12-31 | $15.48M 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |